ECEESPE2025 Poster Presentations MTEabolism, Nutrition and Obesity (125 abstracts)
1Endocrinology Department, Institut de Recerca Sant Joan de Déu, University of Barcelona, 08950 Esplugues, Barcelona, Spain; 2Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, 28029, Madrid, Spain; 3Network Biomedical Research Center of Physiopathology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III, 28029, Madrid, Spain; 4Department of Biomedicine, Institut de Recerca Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; 5Biochemistry and Molecular Biomedicine Department, Institute of Biomedicine, University of Barcelona, and Institut de Recerca Sant Joan de Déu 08950, Esplugues, Barcelona, Spain; 6Pediatric Endocrinology Research Group, Girona Institute for Biomedical Research (IDIBGI), Faculty of Medicine, University of Girona., Dr. Josep Trueta Hospital, 17007 Girona, Spain., Girona, Spain; 7Leuven Research & Development, University of Leuven., Leuven, Belgium
JOINT2844
Introduction: Infants born small-for-gestational age [SGA, birth weight (BW) ≤-2 SD for gestational age (GA)] who experience marked catch-up growth are at risk for subsequent insulin resistance and body adiposity. The mechanisms underlying these associations are not fully delineated. Exosomes are extracellular vesicles mediating intercellular communication, and their cargo (including DNAs, RNAs and proteins) may contribute to altered crosstalk among tissues. We tested in SGA infants whether the profile of exosomal miRNAs at birth differs from that in AGA infants and, if so, whether differentially expressed miRNAs in SGA newborns associate with measures of catch-up growth and insulin resistance up to the postnatal ages of 4 and 12 months.
Subjects and Methods: miRNAs profile in cord blood-derived exosomes was assessed by high-throughput small-RNA sequencing in 10 SGA and 10 appropriate-for-gestational-age (AGA, birth weight between -1 SD and + 1 SD for GA) infants. Differentially expressed miRNAs with a log2 fold change ≥2. 4 or ≤-2. 4 were validated by RT-qPCR in 40 AGA and 35 SGA infants and correlated with anthropometric, body composition (by DXA) and endocrine-metabolic [glucose, insulin, HOMA-IR] parameters at the postnatal ages of 4 and 12 months. Target genes prediction for all differentially regulated miRNAs was obtained with the miRSystem and enrichment analysis was performed using DAVID software.
Results: Six exosomal miRNAs were found to be differentially expressed in SGA infants who subsequently developed spontaneous catch-up growth; miR-1-3p, miR-133a-3p and miR-206 were down-regulated (all P <0. 0001 vs AGA) whereas miR-372-3p, miR-519d-3p and miR-1299 were up-regulated (P between 0. 03 and <0. 0001 vs AGA). The target genes of these miRNAs relate to insulin, RAP1, TGF-beta and neurotrophin signaling. Receiver operating characteristic (ROC) analysis disclosed that these miRNAs could distinguish SGA from AGA infants (0. 65<AUC<0. 99; P between 0. 03 and <0. 0001). The expression levels of these miRNAs associated with BMI and HOMA-IR at 4 and 12 months of age (P between 0. 01 and <0. 001). Up-regulated miRNAs in SGA newborns associated also with gains of total and abdominal fat during infancy (all P between 0. 05 and 0. 009).
Conclusion: The exosomal miRNA profile of SGA infants at birth was found to differ from that of AGA infants, and to associate with measures of catch-up growth, insulin resistance, and body adiposity into late infancy. Further follow-up will disclose to which extent these associations persist into childhood, puberty and adolescence.